Antibody-drug conjugate

Results: 51



#Item
1Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

Add to Reading List

Source URL: visterrainc.com

Language: English - Date: 2017-10-03 19:39:52
    2Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

    Visterra Awarded CARB-X Contract to Advance Development of VIS705 – VIS705 is Visterra’s Novel Antibody-Drug Conjugate Candidate for the Treatment of Deadly Pseudomonas Bacterial Infections – – Contract Valued at

    Add to Reading List

    Source URL: www.visterrainc.com

    Language: English - Date: 2017-10-03 19:39:52
      3OUTSOURCING  Highly potent market growth Highly potent small-molecule and biologic drugs are typically considered to be those APIs that have an occupational

      OUTSOURCING Highly potent market growth Highly potent small-molecule and biologic drugs are typically considered to be those APIs that have an occupational

      Add to Reading List

      Source URL: www.fermion.fi

      Language: English - Date: 2016-04-07 08:11:40
      4FAKULTÄT FÜR CHEMIE  Einladung zum Vortrag von __________________________________________________________________________  Dr. Gonçalo Bernardes

      FAKULTÄT FÜR CHEMIE Einladung zum Vortrag von __________________________________________________________________________ Dr. Gonçalo Bernardes

      Add to Reading List

      Source URL: chemie.univie.ac.at

      Language: English - Date: 2016-03-10 06:54:20
      5Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 217 Pharmacometric Models for Antibody Drug Conjugates and Taxanes in HER2+ and HER2Breast Cancer

      Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 217 Pharmacometric Models for Antibody Drug Conjugates and Taxanes in HER2+ and HER2Breast Cancer

      Add to Reading List

      Source URL: uu.diva-portal.org

      Language: English - Date: 2016-05-25 07:51:34
      6[ Industry Watch ]  JAPAN Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Daiichi Sankyo

      [ Industry Watch ] JAPAN Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Daiichi Sankyo

      Add to Reading List

      Source URL: www.asiabiotech.com

      Language: English - Date: 2008-08-21 23:20:14
        7Diamond Analytics Application Note: DA1018-A  FLARE Wide Pore C18 Column: Separation of Antibody Drug Conjugate (ADC) Digested Sample  Brentuximab-Vedotin was digested with endoproteinase Lys-C

        Diamond Analytics Application Note: DA1018-A FLARE Wide Pore C18 Column: Separation of Antibody Drug Conjugate (ADC) Digested Sample Brentuximab-Vedotin was digested with endoproteinase Lys-C

        Add to Reading List

        Source URL: www.diamond-analytics.com

        - Date: 2015-04-02 20:08:15
          8Award ID: DP150039 Project Title: Armada Pharmaceuticals Inc. New Company Formation for Development of Anti-Cancer Antibody-Drug Conjugate Therapeutics Award Mechanism:

          Award ID: DP150039 Project Title: Armada Pharmaceuticals Inc. New Company Formation for Development of Anti-Cancer Antibody-Drug Conjugate Therapeutics Award Mechanism:

          Add to Reading List

          Source URL: www.cprit.state.tx.us

          Language: English - Date: 2015-03-24 12:30:06
          9The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe

          The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe

          Add to Reading List

          Source URL: www.ceruleanrx.com

          Language: English - Date: 2015-06-01 11:12:23
          10Draft Labeling Text - Redline, 2014Oct23

          Draft Labeling Text - Redline, 2014Oct23

          Add to Reading List

          Source URL: www.seattlegenetics.com

          Language: English - Date: 2015-02-23 11:26:31